Discussion - session III

Source: Research Seminar 2009 - The rationale and use of surfactant and continuous positive airway pressure (CPAP) in extremely low gestational age neonates (ELGANs)

Number: 15

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Discussion - session III. Research Seminar 2009 - The rationale and use of surfactant and continuous positive airway pressure (CPAP) in extremely low gestational age neonates (ELGANs)

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Discussion - session II Source: Research Seminar 2009 - The rationale and use of surfactant and continuous positive airway pressure (CPAP) in extremely low gestational age neonates (ELGANs) Year: 2009
Discussion - session I Source: Research Seminar 2009 - The rationale and use of surfactant and continuous positive airway pressure (CPAP) in extremely low gestational age neonates (ELGANs) Year: 2009
Discussion and feedback regarding the practical session Source: International Congress 2016 – PD1 Spirometry: Train the trainer Year: 2016
Discussion and Q/A Source: Virtual Congress 2020 – Physiology Year: 2020
Discussion and Q&A Source: Virtual Congress 2021 – Inhale the future: ambulatory sensing technologies, digital biomarkers and explainable insights Year: 2021
Discussion and Q&A Source: Virtual Congress 2021 – Linking scientific mechanisms to recent clinical therapeutic advances in airway disease: why, who, when and what? Year: 2021
Discussion and Q&A Source: Virtual Congress 2021 – Rare lung diseases 2021 Year: 2021